Pediatrics News

One dose of the 9-valent HPV vaccine generated a sustained immune response against two prominent cancer-causing types of the virus for up to 2 years, according study findings published in Pediatrics.

More than one-fourth of children in the United States had delayed or missed preventive care due to the COVID-19 pandemic, according to a recent study published in JAMA Network Open.

The FDA on Monday approved a monoclonal antibody for the prevention of respiratory syncytial virus lower respiratory tract disease in newborn and infants.

Last month, Pfizer announced that it was facing a “limited supply and impending stock out” for two of its injectable penicillin products, in part because of a surge in syphilis infections.

American Indian and Alaska Native children endure high rates of respiratory syncytial virus infection, a study published in Pediatrics found.

In 2021, unintentional opioid toxicity was attributed to one in 22 deaths among all adults and one in 10 deaths among those aged 15 to 19 years, a recent study found.

Cannabis-involved emergency department visits among children, teens and young adults in the United States increased during the COVID-19 pandemic, a study published in MMWR found.

Takeda’s dengue vaccine candidate is no longer under review for approval in the United States.

Children treated during prehospital encounters with emergency medical services often do not receive medication doses that are concordant with national guidelines, according to a study published in Pediatrics.

Children with mitochondrial disorders have altered B cell function, which weakens their immune response to viral infections, according to study results published in Frontiers in Immunology.